# SP7

## Overview
The SP7 gene, also known as Osterix, encodes a transcription factor that plays a pivotal role in osteoblast differentiation and bone formation. The protein product, Sp7 transcription factor, is characterized as a zinc finger transcription factor due to its three C2H2-type zinc finger domains, which are crucial for its DNA-binding capabilities (Hojo2022Sp7). As a transcription factor, Sp7 regulates the expression of genes essential for bone mineralization and skeletal development, acting downstream of the RUNX2 transcription factor in the osteogenic pathway (Lui2022A; Liu2020Recent). Mutations in the SP7 gene are associated with various skeletal disorders, including osteogenesis imperfecta and dentinogenesis imperfecta, underscoring its clinical significance in bone and dental health (Bae2018Specificity; AlMutairi2024A).

## Structure
The SP7 transcription factor, also known as Osterix, is a crucial protein for osteoblast differentiation and bone formation. It is characterized by its three C2H2-type zinc finger domains located at the C terminus, which are essential for its DNA-binding capability (Hojo2022Sp7). These zinc fingers are homologous to those found in other Sp family transcription factors, such as Sp1, Sp3, and Sp4, and are indicative of its role as a transcription factor (Hojo2022Sp7). The zinc finger domain is particularly important for the sequence-specific DNA binding function of SP7, and mutations in this domain can lead to pathogenic outcomes (Fiscaletti2018Novel).

SP7 also contains a proline-rich transactivation domain at its N terminus, which contributes to its function as a transcription factor (Hojo2022Sp7). The protein is subject to post-translational modifications, including phosphorylation by p38 MAPK, which influences its interaction with co-activators and its degradation, and acetylation by p300/CBP, enhancing its stability and transactivation ability (Hojo2022Sp7). Alternative splicing of the SP7 gene results in different isoforms, which may affect its function, although specific details on these isoforms are not provided in the context (Hojo2022Sp7).

## Function
The SP7 gene, also known as Osterix, encodes a transcription factor that is essential for osteoblast differentiation and bone formation. In healthy human cells, SP7 functions primarily in the nucleus of osteoblasts, where it binds to specific DNA sequences to regulate the transcription of genes involved in bone mineralization and skeletal development (Lui2022A; Liu2020Recent). SP7 acts downstream of the RUNX2 transcription factor, which is necessary for the differentiation of mesenchymal stem cells into pre-osteoblasts. SP7 is crucial for the subsequent maturation of these pre-osteoblasts into fully differentiated osteoblasts (Milona2003Expression; Lui2022A).

SP7 regulates the expression of several osteoblast-specific genes, including osteocalcin, osteonectin, osteopontin, bone sialoprotein, and type I collagen, which are necessary for bone formation and mineralization (Milona2003Expression; Liu2020Recent). It also plays a role in the maturation of osteocytes, the cells responsible for maintaining bone tissue, by promoting the formation of dendrites and enhancing intercellular communication through connexin 43 (AlMutairi2024A). The transcription factor is also involved in regulating chondrocyte differentiation and maturation, contributing to overall skeletal morphogenesis (AlMutairi2024A).

## Clinical Significance
Mutations in the SP7 gene, also known as Osterix, are associated with several skeletal disorders. Pathogenic variants in SP7 have been linked to osteogenesis imperfecta (OI) type XII, a condition characterized by bone fragility, hearing impairment, and craniofacial anomalies. Specific mutations, such as a homozygous frameshift mutation, result in multiple fragility fractures and mild bone deformities, while the c.946C > T; p.Arg316Cys missense variant leads to low-trauma fractures and craniofacial anomalies (Wang2021Control; AlMutairi2024A). The S309W variant is associated with a high-turnover bone disorder, affecting osteoblastic differentiation and altering SP7's DNA binding specificity, which results in skeletal abnormalities like increased bone thickness and altered mineralization patterns (Lui2022A).

SP7 mutations also impact dental tissue development, leading to conditions such as dentinogenesis imperfecta, characterized by defective dentin and enamel synthesis (Bae2018Specificity). The gene's role in osteocyte biology is significant, as mutations can lead to defects in osteocyte morphology, increased cortical porosity, and abnormal bone remodeling, contributing to conditions like osteoporosis (Wang2021Control). These findings underscore the clinical significance of SP7 in bone and dental health, highlighting its role in various skeletal diseases.

## Interactions
The SP7 transcription factor, also known as Osterix, is involved in several interactions with other proteins and nucleic acids that are crucial for its function in osteoblast differentiation and bone formation. SP7 interacts with DLX proteins, such as DLX3 and DLX5, which are important for its binding to DNA motifs. The S309W variant of SP7 shows decreased binding affinity to AT-rich motifs and altered interactions with DLX proteins, affecting its transcriptional activity (Lui2022A).

SP7 also interacts with the tumor suppressor protein p53, which inhibits its transcriptional activity by disrupting its interaction with DLX5. This interaction occurs near the zinc-finger domain of SP7, which is crucial for its DNA binding and interaction with DLX5 (Artigas2017p53).

Phosphorylation plays a significant role in SP7's function. The p38 MAPK pathway phosphorylates SP7, enhancing its transcriptional activity by promoting interactions with coactivators such as p300 and Brg1. This phosphorylation is essential for SP7's ability to regulate osteoblast-specific genes (Ortuño2010p38).

SP7 also forms complexes with Runx2, another key transcription factor in osteogenesis. This interaction is regulated by MAPK-mediated phosphorylation, which is necessary for their functional cooperation in the transcriptional osteogenic program (Artigas2014Mitogenactivated).


## References


[1. (Milona2003Expression) Maria-athina Milona, Julie E Gough, and Alasdair J Edgar. Expression of alternatively spliced isoforms of human sp7 in osteoblast-like cells. BMC Genomics, November 2003. URL: http://dx.doi.org/10.1186/1471-2164-4-43, doi:10.1186/1471-2164-4-43. This article has 52 citations and is from a peer-reviewed journal.](https://doi.org/10.1186/1471-2164-4-43)

[2. (Artigas2014Mitogenactivated) Natalia Artigas, Carlos Ureña, Edgardo Rodríguez-Carballo, José Luis Rosa, and Francesc Ventura. Mitogen-activated protein kinase (mapk)-regulated interactions between osterix and runx2 are critical for the transcriptional osteogenic program. Journal of Biological Chemistry, 289(39):27105–27117, September 2014. URL: http://dx.doi.org/10.1074/jbc.m114.576793, doi:10.1074/jbc.m114.576793. This article has 92 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1074/jbc.m114.576793)

[3. (AlMutairi2024A) Dalal A Al-Mutairi, Ali A Jarragh, Basel H Alsabah, Marc N Wein, Wasif Mohammed, and Lateefa Alkharafi. A homozygous sp7/osx mutation causes osteogenesis and dentinogenesis imperfecta with craniofacial anomalies. JBMR Plus, March 2024. URL: http://dx.doi.org/10.1093/jbmrpl/ziae026, doi:10.1093/jbmrpl/ziae026. This article has 3 citations and is from a peer-reviewed journal.](https://doi.org/10.1093/jbmrpl/ziae026)

[4. (Lui2022A) Julian C. Lui, Adalbert Raimann, Hironori Hojo, Lijin Dong, Paul Roschger, Bijal Kikani, Uwe Wintergerst, Nadja Fratzl-Zelman, Youn Hee Jee, Gabriele Haeusler, and Jeffrey Baron. A neomorphic variant in sp7 alters sequence specificity and causes a high-turnover bone disorder. Nature Communications, February 2022. URL: http://dx.doi.org/10.1038/s41467-022-28318-4, doi:10.1038/s41467-022-28318-4. This article has 25 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1038/s41467-022-28318-4)

5. (Wang2021Control) Control of osteocyte dendrite formation by Sp7 and its target gene osteocrin. This article has 1 citations.

[6. (Ortuño2010p38) María José Ortuño, Silvia Ruiz-Gaspà, Edgardo Rodríguez-Carballo, Antonio R.G. Susperregui, Ramon Bartrons, José Luis Rosa, and Francesc Ventura. P38 regulates expression of osteoblast-specific genes by phosphorylation of osterix. Journal of Biological Chemistry, 285(42):31985–31994, October 2010. URL: http://dx.doi.org/10.1074/jbc.m110.123612, doi:10.1074/jbc.m110.123612. This article has 106 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1074/jbc.m110.123612)

[7. (Hojo2022Sp7) Hironori Hojo and Shinsuke Ohba. Sp7 action in the skeleton: its mode of action, functions, and relevance to skeletal diseases. International Journal of Molecular Sciences, 23(10):5647, May 2022. URL: http://dx.doi.org/10.3390/ijms23105647, doi:10.3390/ijms23105647. This article has 19 citations and is from a peer-reviewed journal.](https://doi.org/10.3390/ijms23105647)

[8. (Bae2018Specificity) Ji-Myung Bae, John C Clarke, Harunur Rashid, Mitra D Adhami, Kayla McCullough, Jordan S Scott, Haiyan Chen, Krishna M Sinha, Benoit de Crombrugghe, and Amjad Javed. Specificity protein 7 is required for proliferation and differentiation of ameloblasts and odontoblasts. Journal of Bone and Mineral Research, 33(6):1126–1140, February 2018. URL: http://dx.doi.org/10.1002/jbmr.3401, doi:10.1002/jbmr.3401. This article has 39 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1002/jbmr.3401)

[9. (Artigas2017p53) Natalia Artigas, Beatriz Gámez, Mónica Cubillos-Rojas, Cristina Sánchez-de Diego, José Antonio Valer, Gabriel Pons, José Luis Rosa, and Francesc Ventura. P53 inhibits sp7/osterix activity in the transcriptional program of osteoblast differentiation. Cell Death &amp; Differentiation, 24(12):2022–2031, August 2017. URL: http://dx.doi.org/10.1038/cdd.2017.113, doi:10.1038/cdd.2017.113. This article has 46 citations.](https://doi.org/10.1038/cdd.2017.113)

[10. (Fiscaletti2018Novel) Melissa Fiscaletti, Andrew Biggin, Bruce Bennetts, Karen Wong, Julie Briody, Verity Pacey, Catherine Birman, and Craig F. Munns. Novel variant in sp7/osx associated with recessive osteogenesis imperfecta with bone fragility and hearing impairment. Bone, 110:66–75, May 2018. URL: http://dx.doi.org/10.1016/j.bone.2018.01.031, doi:10.1016/j.bone.2018.01.031. This article has 40 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1016/j.bone.2018.01.031)

[11. (Liu2020Recent) Qian Liu, Mao Li, Shiyi Wang, Zhousheng Xiao, Yuanyuan Xiong, and Guangwei Wang. Recent advances of osterix transcription factor in osteoblast differentiation and bone formation. Frontiers in Cell and Developmental Biology, December 2020. URL: http://dx.doi.org/10.3389/fcell.2020.601224, doi:10.3389/fcell.2020.601224. This article has 125 citations and is from a peer-reviewed journal.](https://doi.org/10.3389/fcell.2020.601224)